Isabella List Updates

Moderate drinking and the brain make an uneasy pairing once the scanners get involved. Researchers have put “moderate” drinkers into imaging machines, and the pictures look far less harmless than the label promises. Moderate Drinking and the Brain Under the ScannerA peer reviewed imaging study gave 88 healthy young adults a moderate dose of alcohol

New research has confirmed what many carers and clinicians have long suspected. Youth in foster care who live with a mental health diagnosis are far more likely to misuse alcohol, cannabis or nicotine than their peers. They also respond less well to the brief support sessions designed to help them cut down. The study appears

Childhoods marked by neglect, abuse or upheaval leave marks that can last well beyond the years they happened. A large new review of research confirms just how far those marks can reach. It links adverse childhood experiences to some of the most serious outcomes a young person can face, including death by suicide. Substance use

New research suggests that childhood trauma carried by fathers long before their own children were even born may still be shaping how those children behave today. A study tracking hundreds of American families has found that children of fathers who experienced adversity growing up are noticeably more likely to show behaviour problems in their early

Ask someone why they can’t put their phone down and they’ll probably laugh it off. Ask them why they can’t cut back on drinking, and the conversation gets heavier fast. Both answers start in the same place: a reward circuit in the brain that doesn’t much care whether the trigger is a text message or

New Yale study suggests key clinical, cognitive, and brain-based differences. Key points Modern high-potency cannabis may be changing the landscape of psychotic disorders. Cannabis psychosis may be more than a temporary drug-induced condition. Continued cannabis (THC) use may triple relapse risk despite taking antipsychotics. Daily use and high-potency THC increase psychosis risk in a dose-dependent

INTRODUCTION: A Crisis Hiding In Plain Sight Two numbers define the scale of the problem. In the United States alone, more than 100,000 people die from opioid-related overdoses every year. Among 15-year-olds in England, 44 per cent have been offered drugs and nearly a quarter have used them. These figures represent the downstream consequences of

For many women navigating perimenopause, a glass of wine at the end of a long day can feel like a well-earned ritual. It takes the edge off the stress, softens the anxiety, and sometimes feels like the only thing that actually helps with sleep. But growing evidence suggests that alcohol and perimenopause are a far

 Background. Cannabidiol (CBD) now dominates consumer health markets worldwide. Manufacturers market it predominantly on the basis of perceived safety. However, CBD carcinogenicity FDA evidence, generated during the pharmaceutical approval process for purified CBD (Epidiolex, GW Research Ltd, NDA 210365), raises substantive concerns that regulators have not communicated to the public, prescribers, or policymakers. Evidence reviewed. This